Stockholm, Sweden

Michael Söderman

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Söderman: Innovator in Endovascular Treatment

Introduction

Michael Söderman is a prominent inventor based in Stockholm, Sweden. He has made significant contributions to the field of medical technology, particularly in the treatment of cerebral vasospasm and vasoconstriction. His innovative approaches have the potential to improve patient outcomes in critical medical situations.

Latest Patents

Söderman holds a patent for a treatment system that addresses cerebral vasospasm and vasoconstriction. The patent details endovascular treatment methods that involve placing a microcatheter in affected vessels. This technique is clinically improved compared to the slow infusion of vasodilating compounds. His patent also features self-expanding stents and stent-like members that are designed to be retrieved, ensuring that nothing is left in the vessel. Additionally, the patent includes drug-eluting stents, resorbable stents, and angiographically imagable coatings, such as tantalum brushes over various system components.

Career Highlights

Michael Söderman is associated with Neurvana Medical, LLC, where he continues to develop innovative medical solutions. His work focuses on enhancing the effectiveness of endovascular treatments, which are crucial for patients experiencing delayed cerebral vasospasm.

Collaborations

Söderman collaborates with notable professionals in the field, including David Ferrera and Joshua A Benjamin. Their combined expertise contributes to the advancement of medical technologies and treatment methodologies.

Conclusion

Michael Söderman is a key figure in the development of innovative treatment systems for cerebral vasospasm. His contributions to medical technology are paving the way for improved patient care and outcomes in critical situations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…